PSY38 A UK Based Cost-Effectiveness Analysis of Dasatinib (Sprycel) 100mg Daily Compared to Imatinib (Glivec) 400mg Daily in Newly Diagnosed Patients With Chronic Myeloid Leukemia (CML)
Abstract
Authors
S. Mealing M. Taylor D. Scott J. Clark M. Mckenna M. Lebmeier I. Gilloteau C. Davis